Omri Amirav-Drory is a general partner at NFX. Prior he was the founding General Partner of Tech.bio, a fund dedicated to empowering scientists to become entrepreneurs and start transformative companies at the intersection of technology and biology. Prior to that, he was the Head of Corpdev at Twist Bioscience and the Founder & CEO of Genome Compiler. He was also a Fulbright postdoctoral research fellow at Stanford University. Dr. Amirav-Drory received his PhD in Biochemistry from Tel-Aviv University.